PVCT
Provectus Biopharmaceuticals Inc.

1,942
Mkt Cap
$18.07M
Volume
359,344.00
52W High
$0.113
52W Low
$0.038
PE Ratio
-2.72
PVCT Fundamentals
Price
$0.0469
Prev Close
$0.043
Open
$0.043
50D MA
$0.0582
Beta
0.20
Avg. Volume
255,223.95
EPS (Annual)
-$0.0113
P/B
-2.93
Rev/Employee
$102,856.67
$53.12
Loading...
Loading...
Provectus Biopharmaceuticals, Inc. is a development stage biopharmaceutical company, which engages in the development of ethical pharmaceuticals for oncology and dermatology indications. Its prescription drugs treat several life-threatening cancers including metastatic melanoma, liver cancer, and breast cancer. The company was founded by Eric A. Wachter on January 17, 2002 and is headquartered in Knoxville, TN.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
6

Frequently Asked Questions

What is Market Cap of Provectus Biopharmaceuticals Inc?
What is the 52-week high for Provectus Biopharmaceuticals Inc?
What is the 52-week low for Provectus Biopharmaceuticals Inc?
What is Provectus Biopharmaceuticals Inc stock price today?
What was Provectus Biopharmaceuticals Inc stock price yesterday?
What is the PE ratio of Provectus Biopharmaceuticals Inc?
What is the Price-to-Book ratio of Provectus Biopharmaceuticals Inc?
What is the 50-day moving average of Provectus Biopharmaceuticals Inc?
How many employees does Provectus Biopharmaceuticals Inc have?

Latest PVCT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.